Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index; 27 of the 46 sources its claims cite were checked for support.

Can coenzyme Q10 alleviate the toxic effect of fenofibrate on skeletal muscle?

Open access
El-Bassouny, Dalia R., Mansour, Alyaa A., Ellakkany, Amany S., Ayuob, Nasra N., AbdElfattah, Amany A. · 2023 · Histochemistry and Cell Biology

Published version of a preprint

Abstract

Fenofibrate (FEN) is an antilipidemic drug that increases the activity of the lipoprotein lipase enzyme, thus enhancing lipolysis; however, it may cause myopathy and rhabdomyolysis in humans. Coenzyme Q10 (CoQ10) is an endogenously synthesized compound that is found in most living cells and plays an important role in cellular metabolism. It acts as the electron carrier in the mitochondrial respiratory chain. This study aimed to elucidate FEN-induced skeletal muscle changes in rats and to evaluate CoQ10 efficacy in preventing or alleviating these changes. Forty adult male rats were divided equally into four groups: the negative control group that received saline, the positive control group that received CoQ10, the FEN-treated group that received FEN, and the FEN + CoQ10 group that received both FEN followed by CoQ10 daily for 4 weeks. Animals were sacrificed and blood samples were collected to assess creatine kinase (CK). Soleus muscle samples were taken and processed for light and electron microscopic studies. This study showed that FEN increased CK levels and induced inflammatory cellular infiltration and disorganization of muscular architecture with lost striations. FEN increased the percentage of degenerated collagen fibers and immune expression of caspase-3. Ultrastructurally, FEN caused degeneration of myofibrils with distorted cell organelles. Treatment with CoQ10 could markedly ameliorate these FEN-induced structural changes and mostly regain the normal architecture of muscle fibers due to its antifibrotic and antiapoptotic effects. In conclusion, treatment with CoQ10 improved muscular structure by suppressing oxidative stress, attenuating inflammation, and inhibiting apoptosis.

Overview

CoChat Summary

TL;DR

In adult male rats, fenofibrate caused skeletal muscle degeneration, fibrosis, apoptosis, and elevated creatine kinase, while coenzyme Q10 co-treatment markedly ameliorated these changes. CoQ10 improved structure and biochemistry but did not fully restore all parameters to control levels.

Key findings

  • FEN increased serum creatine kinase to 1416.47 ± 210.62 versus 753.51 ± 72.06 in controls (p < 0.001); CoQ10 reduced it to 987.54 ± 125.73 (p < 0.001 vs FEN), though it remained higher than control (p = 0.011).
  • FEN increased degenerated soleus muscle fibers to 21.66 ± 3.05%; CoQ10 reduced this to 7.74 ± 0.66% (p < 0.001 vs FEN), still above control (p = 0.008).
  • FEN increased collagen fiber area to 21.75 ± 3.68% versus 4.42 ± 0.98% in controls (p < 0.001); CoQ10 reduced it to 9.14 ± 1.84% (p < 0.001 vs FEN), still above control (p = 0.042).
  • FEN increased caspase-3-positive fiber area to 26.79 ± 4.62% versus 2.06 ± 0.29% in controls (p < 0.001); CoQ10 reduced it to 10.35 ± 2.37% (p < 0.001 vs FEN), still above control (p = 0.005). SDH staining was weak in FEN and moderate after CoQ10.

Methods

  • Forty adult male rats (3–4 months old, 180–200 g) were randomized into four equal groups: negative control (saline), positive control (CoQ10 100 mg/kg/day), FEN (60 mg/kg/day), and FEN + CoQ10, all by gastric tube daily for 4 weeks.
  • Soleus muscle was assessed by H&E, Mallory’s trichrome, SDH histochemistry, caspase-3 immunohistochemistry, and transmission electron microscopy; blood was assayed for creatine kinase.
  • Morphometric measurements used ImageJ, and statistical analysis used SPSS with one-way ANOVA followed by Tukey post-hoc test; p ≤ 0.05 was significant.

Limitations

  • The paper states there was no in-depth analysis of the mechanism of CoQ10’s protective effect and a lack of in-depth biochemical investigations such as tissue oxidative enzymes and troponin.
  • Evident from the text: findings are limited to adult male albino rats over a 4-week treatment period, with no female animals, dose-response assessment, or human data.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1007/s00418-023-02205-5

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Photomicrographs of H & E-stained soleus muscle sections of all experimental rats. (a–c) the control group (a, b) L.S. showing parallel nonbranching muscle fibers with acidophilic cytoplasm (crossed arrow), regular transverse striations (wavy arrows), and multiple peripheral oval nuclei (arrowheads). (c) T.S. showing bundles of polyhedral fibers with peripheral, oval nuclei (arrowheads) and acidophilic cytoplasm (crossed arrows), separated by connective tissue perimysium (arrows). (d–i) the FEN group. (d, e) L.S. showing splitting of muscle fibers (SF) with fat cells (F) in between, disorganized muscle fibers with aggregated nuclei (arrowheads), and areas of lost striations (wavy arrow). (g, h) An excessive amount of connective tissue between the fibers (arrows) with inflammatory cellular infiltrates (black asterisk), a congested blood vessel (curved arrow), and extravasated RBCs (thick arrow). (f, i) T.S. showing excess connective tissue perimysium (arrows) with a congested blood vessel (curved arrow) and fat cells (F). Cytoplasm was fragmented (forked arrow), pale (crossed arrow), and vacuolated (V). (j–l) The FEN + CoQ10 group. (j, k) L.S. showing parallel nonbranching muscle fibers with acidophilic cytoplasm (crossed arrow), regular transverse striations (wavy arrows), and multiple peripheral oval nuclei (arrowheads). (l) T.S. showing bundles of muscle fibers separated by connective tissue perimysium (arrow) containing a blood vessel (curved arrow). (m) Statistical analysis of the percentage of degenerated fibers (mean ± SD) in the soleus muscle within the studied groups. Different letters represent a significant difference at p ≤ 0.05. FEN: fenofibrate; CoQ10: coenzyme Q10; L.S.: longitudinal section; T.S.: transverse section; RBCs: red blood cells. (a, c, d, f, g, i, j, l) scale bar: 100 μm, (b, e, h, k) scale bar: 25 μm
Fig. 1 Photomicrographs of H & E-stained soleus muscle sections of all experimental rats. (a–c) the control group (a, b) L.S. showing parallel nonbranching muscle fibers with acidophilic cytoplasm (crossed arrow), regular transverse striations (wavy arrows), and multiple peripheral oval nuclei (arrowheads). (c) T.S. showing bundles of polyhedral fibers with peripheral, oval nuclei (arrowheads) and acidophilic cytoplasm (crossed arrows), separated by connective tissue perimysium (arrows). (d–i) the FEN group. (d, e) L.S. showing splitting of muscle fibers (SF) with fat cells (F) in between, disorganized muscle fibers with aggregated nuclei (arrowheads), and areas of lost striations (wavy arrow). (g, h) An excessive amount of connective tissue between the fibers (arrows) with inflammatory cellular infiltrates (black asterisk), a congested blood vessel (curved arrow), and extravasated RBCs (thick arrow). (f, i) T.S. showing excess connective tissue perimysium (arrows) with a congested blood vessel (curved arrow) and fat cells (F). Cytoplasm was fragmented (forked arrow), pale (crossed arrow), and vacuolated (V). (j–l) The FEN + CoQ10 group. (j, k) L.S. showing parallel nonbranching muscle fibers with acidophilic cytoplasm (crossed arrow), regular transverse striations (wavy arrows), and multiple peripheral oval nuclei (arrowheads). (l) T.S. showing bundles of muscle fibers separated by connective tissue perimysium (arrow) containing a blood vessel (curved arrow). (m) Statistical analysis of the percentage of degenerated fibers (mean ± SD) in the soleus muscle within the studied groups. Different letters represent a significant difference at p ≤ 0.05. FEN: fenofibrate; CoQ10: coenzyme Q10; L.S.: longitudinal section; T.S.: transverse section; RBCs: red blood cells. (a, c, d, f, g, i, j, l) scale bar: 100 μm, (b, e, h, k) scale bar: 25 μmCC BY · PubMed Central
Fig. 2 Photomicrographs of muscle sections stained with toluidine blue (a–c) and SDH (d–f). (a) The control semithin sections show regular striated myofibrils (wavy arrow) with elongated peripheral nuclei (arrowheads). (b) The FEN group shows irregular sarcolemma (bifid arrows) with irregular displaced nuclei (arrowheads), cytoplasmic vacuole (V), and areas with lost striations (wavy arrows). (c) The FEN + CoQ10 group shows striated myofibrils (wavy arrows) with elongated peripheral nuclei (arrowheads). (d) The control group shows high SDH staining intensity (crossed arrow). (e) The FEN group shows weak intensity (crossed arrow). (f) The FEN + CoQ10 group shows moderate intensity (crossed arrow). FEN: fenofibrate; CoQ10: coenzyme Q10; SDH: succinic dehydrogenase. (a, b, c) scale bar: 10 μm, (d, e, f) scale bar: 100 μm
Fig. 2 Photomicrographs of muscle sections stained with toluidine blue (a–c) and SDH (d–f). (a) The control semithin sections show regular striated myofibrils (wavy arrow) with elongated peripheral nuclei (arrowheads). (b) The FEN group shows irregular sarcolemma (bifid arrows) with irregular displaced nuclei (arrowheads), cytoplasmic vacuole (V), and areas with lost striations (wavy arrows). (c) The FEN + CoQ10 group shows striated myofibrils (wavy arrows) with elongated peripheral nuclei (arrowheads). (d) The control group shows high SDH staining intensity (crossed arrow). (e) The FEN group shows weak intensity (crossed arrow). (f) The FEN + CoQ10 group shows moderate intensity (crossed arrow). FEN: fenofibrate; CoQ10: coenzyme Q10; SDH: succinic dehydrogenase. (a, b, c) scale bar: 10 μm, (d, e, f) scale bar: 100 μmCC BY · PubMed Central
Fig. 3 Photomicrographs of Mallory’s trichrome-stained sections. (a) A minimal amount of collagen fibers (arrows) between the control muscle fibers. (b) An excessive amount of collagen between FEN group muscle fibers (arrows) and around blood vessels (asterisk). (c) A little amount of collagen between the FEN + CoQ10 muscle fibers (arrows) and around blood vessels (asterisk). (d) Statistical analysis of the percentage area of collagen fibers (mean ± SD) within the studied groups. Different letters represent a significant difference at p ≤ 0.05. FEN: fenofibrate; CoQ10: coenzyme Q10. (a, b, c) scale bar: 100 μm
Fig. 3 Photomicrographs of Mallory’s trichrome-stained sections. (a) A minimal amount of collagen fibers (arrows) between the control muscle fibers. (b) An excessive amount of collagen between FEN group muscle fibers (arrows) and around blood vessels (asterisk). (c) A little amount of collagen between the FEN + CoQ10 muscle fibers (arrows) and around blood vessels (asterisk). (d) Statistical analysis of the percentage area of collagen fibers (mean ± SD) within the studied groups. Different letters represent a significant difference at p ≤ 0.05. FEN: fenofibrate; CoQ10: coenzyme Q10. (a, b, c) scale bar: 100 μmCC BY · PubMed Central
Fig. 4 Photomicrographs of anti-caspase-3 immunostained sections. (a) The control muscle fibers show a negative caspase-3 immune reaction. (b) A positive reaction in the cytoplasm (crossed arrows) of FEN group muscle fibers. (c) A mild positive reaction in the cytoplasm of the FEN + CoQ10 muscle fibers (crossed arrows). (d) Statistical analysis of the percentage area of caspase-3-positive fibers (mean ± SD) within the studied groups. Different letters represent a significant difference at p ≤ 0.05. FEN: fenofibrate; CoQ10: coenzyme Q10. (a, b, c) scale bar: 100 μm
Fig. 4 Photomicrographs of anti-caspase-3 immunostained sections. (a) The control muscle fibers show a negative caspase-3 immune reaction. (b) A positive reaction in the cytoplasm (crossed arrows) of FEN group muscle fibers. (c) A mild positive reaction in the cytoplasm of the FEN + CoQ10 muscle fibers (crossed arrows). (d) Statistical analysis of the percentage area of caspase-3-positive fibers (mean ± SD) within the studied groups. Different letters represent a significant difference at p ≤ 0.05. FEN: fenofibrate; CoQ10: coenzyme Q10. (a, b, c) scale bar: 100 μmCC BY · PubMed Central
Fig. 5 Electron photomicrographs of the soleus muscle of all experimental rats. (a–c) the control group: (a, b) The normal banding pattern of the myofibrils of the control rat muscle with alternating I band (I) and A band (A). Z lines (bifid arrows) appear in the middle of the I band, the H band (wavy arrow) is bisected by the M line (M). Mitochondria (arrowheads) are seen between the myofibrils. The sarcoplasmic reticulum (S) is seen at the A–I junction. The nucleus (N) is peripheral, oval, and euchromatic. (c) The characteristic triad of skeletal muscle formed of one T tubule (crossed arrow) and two cisternae (S) of sarcoplasmic reticulum. Also, glycogen granules (arrow) and mitochondria (arrowhead) between the myofibrils. (d–f) the FEN group: (d, e) The myofibrils show irregular and disrupted sarcolemma (wavy arrow), areas of degeneration (arrows), irregular Z lines (bifid arrow), abnormal-shaped mitochondria (arrowheads), and irregular-shaped nucleus (N) with the irregular nuclear envelope (black arrowhead). (f) The myofibrils show dilated sarcoplasmic reticulum (S), degenerated mitochondria (arrowheads), and disrupted Z lines (bifid arrows). (g–i) The FEN + CoQ10 group myofibrils show preserved normal banding pattern with alternating I bands (I) and A bands (A). Z lines (bifid arrows) appear in the middle of the I band and M line (M) appears in the middle of the H band (wavy arrow). Mitochondria (arrowheads) are arranged in pairs around Z lines and a few glycogen granules (curved arrows) are seen. The nucleus (N) is peripheral and oval. Notice the presence of few foci of degeneration (arrow) and dilated sarcoplasmic reticulum (S). FEN: Fenofibrate; CoQ10: coenzyme Q10. (a, b, d, e, g, h) scale bar: 0.1 μm. (c, f, i) scale bar: 500 nm
Fig. 5 Electron photomicrographs of the soleus muscle of all experimental rats. (a–c) the control group: (a, b) The normal banding pattern of the myofibrils of the control rat muscle with alternating I band (I) and A band (A). Z lines (bifid arrows) appear in the middle of the I band, the H band (wavy arrow) is bisected by the M line (M). Mitochondria (arrowheads) are seen between the myofibrils. The sarcoplasmic reticulum (S) is seen at the A–I junction. The nucleus (N) is peripheral, oval, and euchromatic. (c) The characteristic triad of skeletal muscle formed of one T tubule (crossed arrow) and two cisternae (S) of sarcoplasmic reticulum. Also, glycogen granules (arrow) and mitochondria (arrowhead) between the myofibrils. (d–f) the FEN group: (d, e) The myofibrils show irregular and disrupted sarcolemma (wavy arrow), areas of degeneration (arrows), irregular Z lines (bifid arrow), abnormal-shaped mitochondria (arrowheads), and irregular-shaped nucleus (N) with the irregular nuclear envelope (black arrowhead). (f) The myofibrils show dilated sarcoplasmic reticulum (S), degenerated mitochondria (arrowheads), and disrupted Z lines (bifid arrows). (g–i) The FEN + CoQ10 group myofibrils show preserved normal banding pattern with alternating I bands (I) and A bands (A). Z lines (bifid arrows) appear in the middle of the I band and M line (M) appears in the middle of the H band (wavy arrow). Mitochondria (arrowheads) are arranged in pairs around Z lines and a few glycogen granules (curved arrows) are seen. The nucleus (N) is peripheral and oval. Notice the presence of few foci of degeneration (arrow) and dilated sarcoplasmic reticulum (S). FEN: Fenofibrate; CoQ10: coenzyme Q10. (a, b, d, e, g, h) scale bar: 0.1 μm. (c, f, i) scale bar: 500 nmCC BY · PubMed Central
Fig. 6 Statistical analysis of the total CK level (mean ± SD) within the studied groups. Different letters represent a significant difference at p ≤ 0.05
Fig. 6 Statistical analysis of the total CK level (mean ± SD) within the studied groups. Different letters represent a significant difference at p ≤ 0.05CC BY · PubMed Central

Verification

Claims the paper makes

22 Valid · 1 Not valid · 17 Not checked · 39 Own results and interpretations

39 more claims · 3 with their cited sources checked

Create a free account to see all 79 claims and to verify the 3 references still open.

See all claims — free account
  • Probably not a substantial claim. 15
  • It may state two separate claims as one. 20
  • The quote only partly states this claim. 4

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

3 of 3

Citations

Cites

Show all 42 references

Research works printed but not linked: 1

  1. Chhetry M, Jialal I (2020) Lipid Lowering Drug Therapy. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing https://www.ncbi.nlm.nih.gov/books/NBK541128/.

Cited by

See all 2

Metadata

Authors
El-Bassouny, D. R., Mansour, A. A., Ellakkany, A. S., Ayuob, N. N., & AbdElfattah, A. A.
Affiliations
  • Mansoura University (EG)
  • Damietta University (EG)
Corresponding author
AbdElfattah, Amany A.
Venue
Histochemistry and Cell Biology
Published
2023-06-04
Volume
160
Issue
2
Pages
147-158
ISSN
  • 0948-6143 (ISSN-L)
  • 1432-119X
OpenAlex
W4379278545
Cited by
0
References
42
FWCI
0.00
Type
journal article
Language
en
Open access
Licence
Locations
  • Histochemistry and Cell Biology (publishedVersion, cc-by)
  • Research Square (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Mansoura University
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Keywords
fenofibrate, coenzyme Q10, skeletal muscle toxicity, myopathy, rhabdomyolysis, creatine kinase, soleus muscle, myofibrillar degeneration, caspase-3, apoptosis, oxidative stress, muscle inflammation, antifibrotic effect, mitochondrial respiratory chain
MeSH terms
Adult, Animals, Humans, Male, Muscular Diseases, Fenofibrate, Ubiquinone, Muscle, Skeletal, Muscle Fibers, Skeletal, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Can coenzyme Q10 alleviate the toxic effect of fenofibrate on skeletal muscle? https://app.cochat.ai/papers/10.1007/s00418-023-02205-5
The paper
El-Bassouny, D. R., Mansour, A. A., Ellakkany, A. S., Ayuob, N. N., & AbdElfattah, A. A. (2023). Can coenzyme Q10 alleviate the toxic effect of fenofibrate on skeletal muscle? Histochemistry and Cell Biology. https://doi.org/10.1007/s00418-023-02205-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.